Allegro Diagnostics
The profile is currenly unclaimed by the seller. All information is provided by CB Insights.
Founded Year
2006Stage
Acquired | AcquiredTotal Raised
$9.92MValuation
$0000About Allegro Diagnostics
Allegro Diagnostics is a molecular diagnostics company focused on the development and commercialization of genomic tests to support the diagnosis and management of lung cancer. These tests have the potential to enable the early diagnosis, staging and informed treatment of lung cancer and other lung diseases.
Allegro Diagnostics Headquarters Location
650 Albany Street
Boston, Massachusetts, 02118,
United States
617-414-6990
Expert Collections containing Allegro Diagnostics
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
Allegro Diagnostics is included in 2 Expert Collections, including Cancer.
Cancer
3,605 items
Companies researching, developing, or offering products & services that aid in the screening, prevention, diagnosis, management, and treatment of cancer.
Omics
1,267 items
Companies involved in the capture, sequencing, and/or analysis of genomic, transcriptomic, proteomic, and/or metabolomic data
Allegro Diagnostics Patents
Allegro Diagnostics has filed 3 patents.
Application Date | Grant Date | Title | Related Topics | Status |
|---|---|---|---|---|
3/13/2014 | 1/7/2020 | Glucocorticoids, Muscarinic antagonists, Pregnanes, Diketones, Beta blockers | Grant |
Application Date | 3/13/2014 |
|---|---|
Grant Date | 1/7/2020 |
Title | |
Related Topics | Glucocorticoids, Muscarinic antagonists, Pregnanes, Diketones, Beta blockers |
Status | Grant |
Latest Allegro Diagnostics News
Sep 5, 2014
VentureWire , September 04, 2014, (c) 2014 Dow Jones & Company, Inc. Publicly traded Veracyte Inc., a molecular diagnostics company working in the field of molecular cytology, announced an agreement to acquire Allegro Diagnostics Corp. for $21 million. Veracyte said it will pay $7.8 million in cash and $13.2 million in common stock.... Document DJFVW00120140904ea94tn6s5 To continue reading this story login at the top right or try the product Document DJFVW00120140904ea94tn6s5 Exclusive news and deep analysis of what’s really happening with venture capital-backed companies, their investors,and their management teams.
When was Allegro Diagnostics founded?
Allegro Diagnostics was founded in 2006.
Where is Allegro Diagnostics's headquarters?
Allegro Diagnostics's headquarters is located at 650 Albany Street, Boston.
What is Allegro Diagnostics's latest funding round?
Allegro Diagnostics's latest funding round is Acquired.
How much did Allegro Diagnostics raise?
Allegro Diagnostics raised a total of $9.92M.
Who are the investors of Allegro Diagnostics?
Investors of Allegro Diagnostics include Veracyte, Kodiak Venture Partners, Catalyst Health Ventures, Qualifying Therapeutic Discovery Project, Small Business Innovation Research Awards and 5 more.
Who are Allegro Diagnostics's competitors?
Competitors of Allegro Diagnostics include Dilon Technologies, Biodesix, Upromise, AutoGenomics, Integrated Diagnostics and 15 more.
You May Also Like
AngioLogix is a provider of cardiovascular health diagnostics.
Dilon Technologies delivers clinically useful imaging and intra operative systems appropriate for early disease diagnosis and surgical applications. Dilon's cornerstone product, the Dilon Molecular Breast Imaging System, is a high-resolution, compact camera, and is available as a single or dual head camera. The Dilon cameras have been optimized to perform Molecular Breast Imaging (MBI/BSGI) procedure that aids in early detection of breast cancer.
At Nanogen, Inc., the company develop diagnostic products that enable physicians to deliver improved patient care. The company's products allow faster and easier diagnosis, treatment and monitoring of cardiovascular disease and infectious diseases. These products include molecular diagnostic kits and reagents, and rapid test kits, which can be used in urgent care settings or at the point-of-care. Nanogen has pioneered developments in areas involving biomarkers, molecular biology and nanotechnology. The company's business focus is to bring better results to diagnostics and healthcare.
ProteoGenix offers maternal-fetal diagnostics
Hx Diagnostics offers rapid diagnostics for seasonal and emerging infectious diseases.
Akonni Biosystems is a molecular diagnostics (MDx) company that develops, manufactures, and markets integrated molecular diagnostic systems.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.